Search Results 'Cardio 3 Biosciences - mont st guibert'
Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)
Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]
Cardio3 BioSciences named Trends-Tendances Business Tour 2013 Most Innovative Company for Brabant Walloon
Cardio3 BioSciences (Mont-Saint-Guibert, Belgium) has been named winner of the Trends-Tendances Business Tour 2013 Award in the “Innovation” category for the Brabant Walloon region. The Business Tour showcases three companies in each province in the country in [...]
Cardio3 BioSciences to consider launching an IPO on NYSE Euronext Brussels and NYSE Euronext Paris
Latest news from Mont-Saint-Guibert, Belgium – Cardio3 BioSciences SA has recently announced that it is considering raising new funds through an Initial Public Offering on NYSE Euronext Brussels and NYSE Euronext Paris. This is an update to the [...]
Cardio3 BioSciences’ publishes Phase II trial results for stem cell therapy treatment in the JACC and increases its equity by €19 million.
Two exciting new announcements have recently been made by Belgian-based biotechnology company Cardio3 BioSciences(Mont-Saint Guibert, Wallonia). In early April the company announced the publication of Phase II trial results for stem cell therapy C-Cure® in the [...]
